Financial Contrast: P3 Health Partners (NASDAQ:PIII) vs. CVR Medical (OTCMKTS:CRRVF)

CVR Medical (OTCMKTS:CRRVF) and P3 Health Partners (NASDAQ:PIII) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Earnings and Valuation

This table compares CVR Medical and P3 Health Partners”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVR Medical	N/A	N/A	N/A	($0.02)	-0.02
P3 Health Partners	$1.50 billion	0.03	-$135.85 million	($40.18)	-0.13

CVR Medical has higher earnings, but lower revenue than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

CVR Medical has a beta of 34.5, suggesting that its share price is 3,350% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Profitability

This table compares CVR Medical and P3 Health Partners’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVR Medical	N/A	N/A	N/A
P3 Health Partners	-9.07%	-302.33%	-16.72%

Analyst Recommendations

This is a summary of current ratings and recommmendations for CVR Medical and P3 Health Partners, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVR Medical	0	0	0	0	0.00
P3 Health Partners	1	0	1	0	2.00

P3 Health Partners has a consensus target price of $12.50, suggesting a potential upside of 133.43%. Given P3 Health Partners’ stronger consensus rating and higher possible upside, analysts clearly believe P3 Health Partners is more favorable than CVR Medical.

Insider and Institutional Ownership

7.8% of P3 Health Partners shares are held by institutional investors. 17.8% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About P3 Health Partners

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.